Search Results - "Jacobson, Mark A"

Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees by Jacobson, Mark A, Zakaria, Adam, Maung, Zaw, Hart, Colin, McCalmont, Timothy H, Fassett, Marlys, Amerson, Erin

“…Abstract Background mRNA SARS-CoV-2 vaccines are administered to 2 million individuals per day in the United States under US Food and Drug Administration…”
Get full text

Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding by LALEZARI, Jacob P, ABERG, Judith A, WANG, Laurene H, WIRE, Mary Beth, MINER, Richard, SNOWDEN, Wendy, TALARICO, Christine L, SHAW, Shuching, JACOBSON, Mark A, DREW, W. Lawrence

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4⁺ T Cell Recovery on Antiretroviral Therapy by Hunt, Peter W., Martin, Jeffrey N., Sinclair, Elizabeth, Epling, Lorrie, Teague, Juli, Jacobson, Mark A., Tracy, Russell P., Corey, Lawrence, Deeks, Steven G.

“…Background. Elevated immune activation persists during treated human immunodeficiency virus (HIV) infection and is associated with blunted CD4 recovery and…”
Get full text

Temperature Screening of Healthcare Personnel Is Ineffective in Controlling COVID-19 by Maung, Zaw, Kristensen, Marissa, Hoffman, Bridget, Jacobson, Mark A.

“…Our aim was to describe the effectiveness of employee temperature screening at a public hospital in San Francisco during the COVID-19 pandemic. An estimated…”
Get full text

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit by Wohl, David A, Kendall, Michelle A, Feinberg, Judith, Alston-Smith, Beverly, Owens, Susan, Chafey, Suzette, Marco, Michael, Maxwell, Sharon, Benson, Constance, Keiser, Philip, van der Horst, Charles, Jacobson, Mark A

“…Despite the efficacy and tolerability of modern antiretroviral therapy (ART), many patients with advanced AIDS prescribed these regimens do not achieve viral…”
Get full text

Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients by Jacobson, Mark A, Ditmer, Dirk P, Sinclair, Elizabeth, Martin, Jeffrey N, Deeks, Steven G, Hunt, Peter, Mocarski, Edward S, Shiboski, Caroline

“…Most HIV-infected patients receiving virologically suppressive antiretroviral therapy continue to have abnormal, generalized T cell activation. We explored…”
Get full text

Protective Immunity to Cytomegalovirus (CMV) Retinitis in AIDS Is Associated with CMV-Specific T Cells That Express Interferon-γ and Interleukin-2 and Have a CD8+ Cell Early Maturational Phenotype by Sinclair, Elizabeth, Tan, Qi Xuan, Sharp, Margaret, Girling, Valerie, Poon, Chungkee, Natta, Mark Van, Jabs, Douglas A., Inokuma, Margaret, Maecker, Holden T., Bredt, Barry

“…To determine potential correlates of immune recovery from AIDS-related cytomegalovirus retinitis (CMVR), multiparameter flow cytometry was used to characterize…”
Get full text

Risk of subsequent SARS‐CoV‐2 infection among vaccinated employees with or without hybrid immunity acquired early in the Omicron‐predominant era of the COVID‐19 pandemic by Jacobson, Mark A., Blanc, Paul D., Tulsky, Jacqueline, Tilly, Monica, Meister, Raymond, Huen, Will, McNicholas, James E.

“…Background Hybrid immunity, from COVID‐19 vaccination followed by SARS‐CoV‐2 infection acquired after its Omicron variant began predominating, has provided…”
Get full text

Trafficking of Human Immunodeficiency Virus Type 1-Specific CD8+ T Cells to Gut-Associated Lymphoid Tissue during Chronic Infection by Shacklett, Barbara L, Cox, Catherine A, Sandberg, Johan K, Stollman, Neil H, Jacobson, Mark A, Nixon, Douglas F

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Do CD4+ T cell functional responses to Epstein-Barr virus provide protective immunity against CNS lymphoma in AIDS? by Jacobson, Mark A

“…Jacobson discusses a new study addressing the question of whether an EBV antigen-specific T cell response might be a critical component of protective immunity…”
Get full text

A Rapid Nucleic Acid Amplification Test–Based, Conditional Release-to-Work Policy for Health Care Personnel With Symptoms Consistent With COVID-19 by Jacobson, Mark A., Hart, Colin, Huen, Will, Suarez Guardado, Griselda, Villanueva, Allyson, Whitman, Jeffrey, Blanc, Paul D.

“…Most health care personnel (HCP) reporting symptoms consistent with COVID-19 illness are assessed by high-accuracy SARS-CoV-2 assays performed in clinical…”
Get full text

Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapy by Shiboski, Caroline H, Lee, Anthony, Chen, Huichao, Webster-Cyriaque, Jennifer, Seaman, Todd, Landovitz, Raphael J, John, Malcolm, Reilly, Nancy, Naini, Linda, Palefsky, Joel, Jacobson, Mark A

“…OBJECTIVE:The incidence of human papillomavirus (HPV)-related oral malignancies is increasing among HIV-infected populations, and the prevalence of oral warts…”
Get full text

Phase 1 Trial of a Single Dose of Recombinant Human Interleukin-12 in Human Immunodeficiency Virus-Infected Patients with 100-500 CD4 Cells/μL by Jacobson, Mark A., Hardy, David, Connick, Elizabeth, Watson, Jessica, DeBruin, Michael

“…A phase 1 dose-escalation trial of a single subcutaneous dose of recombinant human (rh) interleukin (IL)-12 was conducted in medically stable human…”
Get full text

Results of a Cytomegalovirus (CMV)-Specific CD8+/Interferon-γ+ Cytokine Flow Cytometry Assay Correlate with Clinical Evidence of Protective Immunity in Patients with AIDS with CMV Retinitis by Jacobson, Mark A., Maecker, Holden T., Orr, Patricia L., D'Amico, Ron, Van Natta, Mark, Li, Xiao-Dong, Pollard, Richard B., Bredt, Barry M.

“…To evaluate the potential clinical utility of a cytomegalovirus (CMV)-specific CD8+/interferon (IFN)-γ+ cytokine flow cytometry (CFC) assay for patients with…”
Get full text

Cytomegalovirus (CMV)–Specific CD4+ T Lymphocyte Immune Function in Long-Term Survivors of AIDS-Related CMV End-Organ Disease Who Are Receiving Potent Antiretroviral Therapy by Jacobson, Mark A., Schrier, Rachel, McCune, Joseph M., Torriani, Francesca J., Holland, Gary N., O’Donnell, James J., Freeman, William R., Bredt, Barry M.

“…To better understand the relation of cytomegalovirus (CMV)–specific CD4+ T lymphocyte immunity and clinical outcome in AIDS-related CMV end-organ disease, 2…”
Get full text

Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS by Weinberg, Adriana, Bosch, Ronald, Bennett, Kara, Tovar-Salazar, Adriana, Benson, Constance A, Collier, Ann C, Zolopa, Andrew, Gulick, Roy M, Wohl, David, Polsky, Bruce, Erice, Alejo, Jacobson, Mark A

“…OBJECTIVES:Cytomegalovirus (CMV)-specific T-cell effectors (CMV-Teff) protect against CMV end-organ disease (EOD). In HIV-infected individuals, their numbers…”
Get full text

Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses by Hartigan-O'Connor, Dennis J., Jacobson, Mark A., Tan, Qi Xuan, Sinclair, Elizabeth

“…Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and…”
Get full text

A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain) by Jacobson, Mark A, Adler, Stuart P, Sinclair, Elizabeth, Black, Douglas, Smith, Anna, Chu, Alice, Moss, Ron B, Wloch, Mary K

“…Abstract CMV-seronegative subjects vaccinated intramuscularly or intradermally with a DNA vaccine encoding pp65, IE1, and gB were administered live-attenuated…”
Get full text

Granulocyte-Macrophage Colony-Stimulating Factor Induces Modest Increases in Plasma Human Immunodeficiency Virus (HIV) Type 1 RNA Levels and CD4+ Lymphocyte Counts in Patients with Uncontrolled HIV Infection by Jacobson, Jeffrey M., Lederman, Michael M., Spritzler, John, Valdez, Hernan, Tebas, Pablo, Skowron, Gail, Wang, Rui, Jackson, J. Brooks, Fox, Lawrence, Landay, Alan, Gilbert, Mark J., O’Neil, Dorothy, Bancroft, Lynne, Al-Harthi, Lena, Jacobson, Mark A., Merigan, Thomas C.

“…BackgroundStudies have reported that plasma human immunodeficiency virus type 1 (HIV-1) RNA levels and CD4+ lymphocyte counts in HIV-infected patients improved…”
Get full text

Association of Cytomegalovirus (CMV)–Specific CD4+ T Lymphocyte Reactivity and Protective Immunity against Acquired Immunodeficiency Syndrome–Related CMV Retinitis by Jacobson, Mark A., Bredt, Barry M.

Get full text